ClearPoint Neuro
CLPT
ClearPoint Neuro (CLPT) analyst forecast and price target
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| B. Riley Securities | Maintained | Buy | $30.00 from $20.00 | Jun 18, 2026 |
| B. Riley Securities | Maintained | Buy | $20.00 from $18.00 | Mar 18, 2026 |
| B. Riley Securities | Maintained | Buy | $18.00 from $28.00 | Mar 5, 2026 |
| Stifel | Maintained | Buy | $9.00 from $8.00 | Aug 1, 2025 |
| Stifel | Maintained | Buy | $25.00 from $19.00 | Apr 1, 2025 |
| B. Riley Securities | Maintained | Buy | $20.00 from $15.00 | Jan 28, 2025 |
| Lake Street | Maintained | Buy | $30.00 from $17.00 | Jan 21, 2025 |
| Lake Street | Maintained | Buy | $15.00 from $11.00 | Aug 27, 2024 |
| Stifel | Maintained | Buy | $9.00 from $8.00 | Mar 13, 2024 |
| Stifel | Initiated Coverage | Buy | $8.00 | Oct 24, 2023 |
| Lake Street | Maintained | Buy | $15.00 from $22.00 | Aug 9, 2023 |
Frequently asked questions
What is the latest analyst rating on CLPT?
On Jun 18, 2026, B. Riley Securities maintained ClearPoint Neuro at Buy with a price target of $30.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.